| Year |
Citation |
Score |
| 2024 |
Min GJ, Park SS, Park S, Yoon JH, Lee SE, Cho BS, Eom KS, Kim HJ, Lee S, Min CK, Cho SG, Kim YJ. Beneficial effects of cellular immunotherapy in the prevention and treatment of posttransplant hematologic relapse of myelodysplastic neoplasms. Annals of Hematology. PMID 39500757 DOI: 10.1007/s00277-024-06060-9 |
0.386 |
|
| 2024 |
Park S, Bang SY, Kwag D, Lee JH, Kim TY, Lee J, Min GJ, Park SS, Yahng SA, Jeon YW, Shin SH, Yoon JH, Lee SE, Cho BS, Eom KS, et al. Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1. Bone Marrow Transplantation. PMID 38438648 DOI: 10.1038/s41409-024-02255-w |
0.567 |
|
| 2022 |
Park S, Kwag D, Kim TY, Lee JH, Lee JY, Min GJ, Park SS, Yahng SA, Jeon YW, Shin SH, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, et al. A retrospective comparison of salvage intensive chemotherapy venetoclax-combined regimen in patients with relapsed/refractory acute myeloid leukemia (AML). Therapeutic Advances in Hematology. 13: 20406207221081637. PMID 35340720 DOI: 10.1177/20406207221081637 |
0.505 |
|
| 2021 |
Park S, Kim TY, Lee JH, Lee JY, Min GJ, Park SS, Yahng SA, Shin SH, Yoon JH, Lee SE, Cho BS, Eom KS, Lee S, Kim HJ, Min CK, et al. Differential effects of donor lymphocyte infusion upon treatment response and GVHD according to relapse level and donor sources in patients with myelodysplastic syndrome. Therapeutic Advances in Hematology. 12: 20406207211043748. PMID 34589195 DOI: 10.1177/20406207211043748 |
0.543 |
|
| 2020 |
Park S, Min GJ, Park SS, Yahng SA, Jeon YW, Shin SH, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, et al. Comparison of myeloablative (CyTBI, BuCy) versus reduced-intensity (FluBu2TBI400) peripheral blood stem cell transplantation in acute myeloid leukemia patients with pre-transplant low WT1 expression. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32659434 DOI: 10.1016/j.bbmt.2020.07.006 |
0.573 |
|
| 2010 |
Ryu J, Lee SR, Park SG, Kang S, Kim HJ, Park BC. Change in serum proteome during allogeneic hematopoietic stem cell transplantation and clinical significance of serum C-reactive protein and haptoglobin. Experimental & Molecular Medicine. 42: 651-61. PMID 20716902 DOI: 10.3858/Emm.2010.42.9.065 |
0.307 |
|
| 2007 |
Kim I, Keam B, Lee KH, Kim JH, Oh SY, Ra EK, Yoon SS, Park SS, Kim CS, Park S, Hong YC, Kim BK. Glutathione S-transferase A1 polymorphisms and acute graft-vs.-host disease in HLA-matched sibling allogeneic hematopoietic stem cell transplantation. Clinical Transplantation. 21: 207-13. PMID 17425746 DOI: 10.1111/j.1399-0012.2006.00624.x |
0.301 |
|
| Show low-probability matches. |